Related Experiment Videos
[Distribution of 4-14C-mofebutazone in the rat]
Abstract:
To further elucidate the distribution and differentiation of mofebutazone in comparison to phenylbutazone, 6 rats received 200 mg/kg 4-14C-mofebutazone corresponding to approx. 27 microCi/animal. 2 animals were sacrificed each time after 45 min, 6 h and 24 h. The 4-14C-plasma level was determined at the corresponding test periods and the radioactivity eliminated within 24 h in the urine was also determined. In addition autoradiograms of the whole animal were prepared for each animal. According to this study 4-14C-mofebutazone is distributed mainly in the metabolisation and elimination organs, a moderate activity was to be found under the skin and muscle tissue, but none, however, in the central nervous system and the bone marrow. Nearly 81% of the substance was eliminated after 24 h and with exception the colon the corresponding autoradiograms were practically free of activity. Because of the short half-life time and the rapid elimination mofebutazone does not lead to any accumulation.
Insights
Mofebutazone rapidly distributes to elimination organs and is quickly excreted, with nearly 81% eliminated in 24 hours. This rapid excretion prevents drug accumulation in rats, suggesting a low risk of toxicity.
Area of Science:
- Pharmacokinetics
- Drug Metabolism
- Toxicology
Background:
- Mofebutazone and phenylbutazone are nonsteroidal anti-inflammatory drugs (NSAIDs).
- Understanding mofebutazone's distribution and elimination is crucial for assessing its safety profile.
- Comparative pharmacokinetic data between mofebutazone and phenylbutazone is limited.
Purpose of the Study:
- To investigate the distribution and elimination of mofebutazone in rats.
- To compare the pharmacokinetic profile of mofebutazone with phenylbutazone.
- To determine the potential for mofebutazone accumulation in tissues.
Main Methods:
- Administered 4-14C-mofebutazone (200 mg/kg) to 6 rats.
- Measured plasma levels and urinary excretion of radioactivity at 45 min, 6 h, and 24 h.
- Utilized whole-body autoradiography to visualize tissue distribution.
Main Results:
- Mofebutazone primarily distributed to metabolization and elimination organs.
- Moderate radioactivity detected in skin and muscle tissue; none in CNS or bone marrow.
- Nearly 81% of the dose was eliminated within 24 hours, mainly via urine.
- Autoradiograms showed minimal residual activity after 24 hours, except in the colon.
Conclusions:
- Mofebutazone exhibits rapid elimination and a short half-life in rats.
- The drug does not appear to accumulate in tissues, indicating a favorable safety profile.
- These findings suggest a lower risk of toxicity compared to drugs with longer elimination times.